Executing Mabion’s CDMO Vision: Insights from CEO Gregor Kawaletz

• Deeper collaboration with biotech through co-development is a hallmark of Mabion Biologics CDMO.
• Gregor Kawaletz discusses how Mabion is positioning itself as a long-term partner for biopharma companies.

In a recent interview, Gregor Kawaletz, CEO of Mabion, shares his perspective on strategic transformation into a specialized partner for biotechnology and pharmaceutical companies.

As the CDMO model evolves, Mabion is expanding beyond manufacturing to offer integrated solutions across the entire biologics process development lifecycle. The interview highlights how this approach supports deeper collaboration and greater value creation for partners. Our CEO addresses the significance of increased management capital involvement, emphasizing how such actions reflect long-term confidence in Mabion’s business model and growth trajectory.

The conversation provides a closer look at:

• Progress in building a robust project pipeline
• Key operational steps to scale the business and drive revenue growth
• Growing interest from global biotech and pharmaceutical companies
• The importance of long-term technological partnerships

By combining technological expertise with a partnership-driven approach, Mabion is strengthening its role in advancing innovative biologics therapies.

The interview was conducted by Anna Wieczorek, Director of the Administration Department and Marika Michorowska, Marketing Specialist.

Prepared by:

Jakub Knurek

Marketing Specialist

j.knurek@mabion.eu

Jakub Knurek

Marketing Specialist

Jakub Knurek is a marketing and business development expert specializing in CDMO operations with scientific and biopharmaceutical background. During the COVID-19 pandemic, he contributed to the development of the Novavax protein vaccine. As a side project, he runs his own pharma company.

As the author of numerous articles, he is recognized as an important voice of the younger generation of scientists. He is a member of Mabion’s representation at industry trade shows, including BIO International Convention 2025 in Boston, 2nd Global Biologics India 2025 in Hydrabad, CPHI 2024 in Milan, CPHI 2023 in Barcelona, Life Sciences Baltics 2023 in Vilnius. He actively participates in academic, business and industry discussions, such as the “Building the Future Pharma Workforce” panel at CPHI Milan 2024.

For further reading

1. Knurek J. Gregor Kawaletz featured on Making It in Manufacturing podcast. Mabion Science Hub. 2026.
2. Behrens D. The evolution of the CDMO model in Central Europe: strategic partnerships as a catalyst for change. Manufacturing Chemist. 2026.